3-Methoxy-4-pyridineboronic acid pinacol ester
Product Information
Molecular Formula
C12H18BNO3
Molecular Weight
235.09
Description
3-Methoxy-4-pyridineboronic acid pinacol ester is a powerful medicinal compound used in the biomedical industry. By targeting specific molecular pathways, this product shows promising efficacy in inhibiting tumor growth and reducing inflammation, making it a valuable asset in drug development and disease research.
Synonyms
3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine; 3-METHOXY-4-PYRIDINEBORONIC ACID PINACOL ESTER; 3-METHOXYPYRIDIN-4-YLBORONIC ACID PINACOL ESTER; Pyridine, 3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-; 3-METHOXY-4-(TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE; 3-Methoxy-4-pyridineboronicacidpinacolester; 3-Methoxy-4-pyridineboronic acid pinacol ester, 97%
IUPAC Name
3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=C(C=NC=C2)OC
InChI
InChI=1S/C12H18BNO3/c1-11(2)12(3,4)17-13(16-11)9-6-7-14-8-10(9)15-5/h6-8H,1-5H3
InChI Key
HLRJDJZOIOTKSF-UHFFFAOYSA-N
Melting Point
146 °C
Flash Point
Not applicable
Purity
97%
Storage
−20°C
Safety Information
Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
2
Exact Mass
235.1379736 g/mol
Monoisotopic Mass
235.1379736 g/mol
Topological Polar Surface Area
40.6Ų
Heavy Atom Count
17
Formal Charge
0
Complexity
267
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-110015987-B | Preparation method of 2,3 '-dimethoxy- [2,4' ] bipyridyl | 2019-05-22 |
| CN-111511742-A | Pyrazolo [3,4-b ] pyridines and imidazo [1,5-b ] pyridazines as PDE1 inhibitors | 2017-12-20 |
| US-2021009571-A1 | Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as pde1 inhibitors | 2017-12-20 |
| JP-2018145180-A | A pharmaceutical comprising a biaryl derivative or a salt thereof | 2017-03-01 |
| JP-2019073537-A | Drug comprising a biaryl derivative or a salt thereof | 2017-03-01 |
| JP-6469272-B2 | A pharmaceutical comprising a biaryl derivative or a salt thereof | 2017-03-01 |
| US-10654834-B2 | Non-systemic TGR5 agonists | 2016-07-01 |
| US-2019330191-A1 | Novel non-systemic tgr5 agonists | 2016-07-01 |
| US-2020308122-A1 | Novel non-systemic tgr5 agonists | 2016-07-01 |
| US-11236055-B2 | Non-systemic TGR5 agonists | 2016-07-01 |
